Skip to main content
Caplight Logo









FerroptoCure Inc.

FerroptoCure Inc.

Private
TokyoHealthcare & Life Scienceshttps://ferroptocure.com/

Last Round

Series A

Sep 19, 2025

Total Funding Raised

$6.91M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

FerroptoCure Inc. is a biotechnology company developing therapeutic drugs designed to control ferroptosis for the treatment of cancer, neurodegenerative disorders, and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

ferroptosisferroptosis induceranticancer drugstreatment-resistant cancersmall molecule drugsclinical stage biopharmaoncologyTriple-Negative Breast CancerTNBCrefractory cancerdrug repurposingoral anticancer drugssolid tumorsdrug discoverypharma licensingcompanion animal healthneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FerroptoCure Inc. Comparables

Compare FerroptoCure Inc. with similar companies based on industry and business-model similarity.

FerroptoCure Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BridgeBio
61%
O2nix Bio
60%
Sumitomo Pharma Co., Ltd.
59%

FerroptoCure Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 19, 2025
SeedJun 5, 2023

FerroptoCure Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 74% MoM.

  • Nov 7, 2025

    Monthly visitors increased 234% MoM, reaching 6K.

FerroptoCure Inc. Filings

Explore SEC and related filing metadata, where available.

FerroptoCure Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about FerroptoCure Inc.'s valuation, stock price, and market status.

Is FerroptoCure Inc. a public or private company?

FerroptoCure Inc. is a private company.

What is the current stock price of FerroptoCure Inc.?

FerroptoCure Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is FerroptoCure Inc. worth (valuation)?

Valuation information for FerroptoCure Inc. is not publicly available.

Can I buy FerroptoCure Inc. stock?

FerroptoCure Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was FerroptoCure Inc.'s last funding round?

FerroptoCure Inc.'s most recent funding round was Series A on September 19, 2025.

Who are the main investors in FerroptoCure Inc.?

Key investors in FerroptoCure Inc. include Organization for Small & Medium Enterprises and Regional Innovation, JAPAN, MIRAISOZO INVESTMENTS Inc., Diamond Medino Capital, 1stRound, Tokyo University of Science Innovation Capital.

Will FerroptoCure Inc. IPO soon?

No public IPO plans have been announced for FerroptoCure Inc..

How can I track FerroptoCure Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FerroptoCure Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range1
Year Founded2022
Last FundingSep 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?